Ziekenhuis Rivierenland
About Ziekenhuis Rivierenland
"Ziekenhuis Rivierenland biedt medisch specialistische zorg en expertise in de regio en draagt daarmee bij aan positieve gezondheid. Bij Ziekenhuis Rivierenland voelt u zich veilig & vertrouwd."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
4
Borstkanker Onderzoek Groep
3
Radboud University Medical Center
3
Amgen
2
Boehringer Ingelheim
2
Dutch Colorectal Cancer Group
2
Pfizer
2
Diakonessenhuis, Utrecht
1
Eli Lilly and Company
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Ferring Pharmaceuticals
1
Clinical Trials at Ziekenhuis Rivierenland
During the past decade, Ziekenhuis Rivierenland conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
2005-10-01
2009-05-01
Unknown status
5,200
Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients
2005-01-01
2008-12-01
Completed
180
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
2005-09-01
2006-05-01
Completed
962
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-06-01
2007-12-01
Completed
545
Feasibility of a Trial Evaluating the Effectiveness of Occupational Therapy in Parkinson's Disease
2009-10-01
2010-06-01
Completed
43
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ziekenhuis Rivierenland" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Borstkanker Onderzoek Groep" with 3 trials
sponsored, "Radboud University Medical Center" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Rivierenland"
#1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Agendia" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "BOOG Study Center" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Ziekenhuis Rivierenland
According to Clinical.Site data, the most researched conditions in "Ziekenhuis Rivierenland" are
"Cardiovascular Disease" (2 trials), "Colorectal Cancer" (2 trials), "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Ziekenhuis Rivierenland" in a lesser frequency.
Clinical Trials Intervention Types at Ziekenhuis Rivierenland
Most popular intervention types in "Ziekenhuis Rivierenland" are "Drug" (14 trials), "Other" (4 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Pitavastatin" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Atorvastatin" (1 trials) and "CDK 4/6 inhibitor" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ziekenhuis Rivierenland
The vast majority of trials in "Ziekenhuis Rivierenland" are
22 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ziekenhuis Rivierenland
Currently, there are NaN active trials in "Ziekenhuis Rivierenland".
undefined are not yet recruiting,
5 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 11 completed trials in Ziekenhuis Rivierenland,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Ziekenhuis Rivierenland, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".